IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Aisling Capital Management LP

Q4 2022 Holdings

Filed 2023-02-09 | 16 holdings | $151.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
BridgeBio Pharma Inc. (Bbio)(BBIO)COM10806X102$46.2M6,068,12530.5%
Verona Pharma plc (Vrna)(VRNA)SPONSORED ADS925050106$34.8M1,332,48523.0%
Syndax Pharmaceuticals, Inc. (Sndx)(SNDX)COM87164F105$26.1M1,025,00017.2%
Monte Rosa Therapeutics Inc. (Glue)(GLUE)COM61225M102$11.2M1,472,3317.4%
Aclaris Theraputics Inc. (Acrs)(ACRS)COM00461U105$6.8M434,4554.5%
Biomea Fusion Inc. (Bmea)(BMEA)COM09077A106$6.7M798,7574.4%
Poseida Therapeutics Inc. (Pstx)(PSTXUSD)COM73730P108$5.5M1,043,2673.7%
Nuvation Bio Inc. (Nuvb)(NUVB)COM CL A67080N101$4.9M2,541,0093.2%
Elevation Oncology Inc. (Elev)COM28623U101$2.7M2,834,9101.8%
Reneo Pharmaceuticals Inc. (Rphm)(RPHM)COM75974E103$2.1M886,0751.4%
Spruce Biosciences, Inc. (Sprb)COM85209E109$1.3M1,205,5110.9%
Marker Therapeutics, Inc. (Mrkr)COM57055L107$848.6K3,142,8570.6%
Aeglea Biotherapeutics Inc. (Agle)(AGLEUSD)COM00773J103$761.0K1,691,1510.5%
Avrobio, Inc. (Avro)COM05455M100$716.9K1,009,7790.5%
Viracta Therapeutics Inc. (Virx)COM92765F108$421.3K288,5710.3%
Atreca Inc. (Bcel)(BCELUSD)CL A COM04965G109$310.5K387,6530.2%